بررسی تأثير تیمار با AntimiR-182 روی افزایش حساسیت به داروی سیس پلاتین در سلول‌های Hela

منابع

Guillermo TL, Eduardol F. Epidemiology of cervical vulvar and vaginal cancer. In: Gershenson DM, Guire WP, Gore M, Quinn MA, Thomas G. Gynecologic cancer controversies in management. Philadelphia:Elsveir;2004:p.913.

Pisani, P., The cancer burden and cancer control in developing countries. Environmental Health, 2011. 10(Suppl 1): p. S2.

Boring CC, Squiers TS, Tong T. Cancer Statics, 1994. CA Cancer Clin 1993; 44:7-26.

H.W. Hwang, J.T. Mendel. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br. J. Cancer, 94 (2006), pp. 776–780

B. Bao, S. Ali, D. Kong, et al. Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancer . PLoS One, 6 (2011), p. e17850

Y. Saito, H. Suzuki, H. Tsugawa, et al. Chromatin remodeling at Alu repeats by epigenetic treatment activates silenced microRNA-512-5p with downregulation of Mcl-1 in human gastric cancer cells. Oncogene, 28 (2009), pp. 2738–2744

Wang Z, Luo X, Lu Y, Yang B. miRNAs at the heart of the matter. J Mol Med 2008; 86: 771-83.

Garzon R, Fabbri M, Cimmino A, Calin GA, Croce CM MicroRNA expression and function in cancer. Trends Mol Med.2006. 12: 580–58

Q. Xie, X. Chen, F. Lu, et al. Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma. Cancer, 2012: 118, pp. 2431–2442

Y. Zhang, W. Wei, N. Cheng, et al Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling. Hepatology, 2012: 56, pp. 1631–1640

Y. Tomimaru, H. Eguchi, H. Nagano, et al. MicroRNA-21 induces resistance to the anti-tumour effect of interferon-alpha/5-fluorouracil in hepatocellular carcinoma cells. Br. J. Cancer, 2010: 103, pp. 1617–1626

T.P. Robin, A. Smith, E. McKinsey, L. Reaves, P. Jedlicka, H.L. Ford. EWS/FLI1 regulates EYA3 in Ewing sarcoma via modulation of miRNA-708, resulting in increased cell survival and chemoresistance. Mol. Cancer Res., 2012: 10, pp. 1098–1108

Elmen, J., et al., LNA-mediated microRNA silencing in non-human primates. Nature, 2008. 452(7189): p. 896-9

R. Lei, J. Tang, X. Zhuang, et al. Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis. Oncogene (2013) http://dx.doi.org/10.1038/onc.2013.65

H. Wang, G. Tan, L. Dong, et al. Circulating MiR-125b as a marker predicting chemoresistance in breast cancer. PLoS One, 2012: 7, p. e34210

Y.Q. Wang, R.D. Guo, R.M. Guo, W. Sheng, L.R. Yin MicroRNA-182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas. J. Cell. Biochem., 2013: 114, pp. 1464–1473

S. Husted, R. Sokilde, L. Rask, et al. MicroRNA expression profiles associated with development of drug resistance in Ehrlich ascites tumor cells Mol. Pharm., 2011: 8, pp. 2055–2062

Tang, T., et al., MicroRNA-182 plays an onco-miRNA role in cervical cancer. Gynecol Oncol, 2013. 129(1): p. 199-208.

Gong, C., et al., Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer. J Biol Chem, 2011. 286(21): p. 19127-37.

Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T Identification of novel genes coding for small expressed RNAs. Science . 2001,294: 853–858

Ambros V. The functions of animal microRNAs. Nature 2004;431:350e355.

Bartel DP. Multiple miRNAs participated in tumorigenesis and development. Cell 2004;116:281e297.

Rajewsky N, Socci ND Computational identification of microRNA targets. Dev Biol. 2004, 267: 529–535

Chen X A microRNA as a translational repressor of APETALA2 in Arabidopsis flower development. Science.2004. 303: 2022–2025

Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature. 2004. 432: 226–230

Munker R, Calin GA. MicroRNA profiling in cancer. Clin Sci (Lond) 2011;121: 141–58.

Esquela-Kerscher A, Slack FJ. Oncomirs — microRNAs with a role in cancer. Nat Rev Cancer 2006;6:259–69.

Hirata H, Ueno K, Shahryari V, Deng G, Tanaka Y, Tabatabai ZL, Hinoda Y, Dahiya R: MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancer. PLoS One 2013, 8:e55502

Chiang CH, Hou MF, Hung WC: Up-regulation of miR-182 by beta-catenin in breast cancer increases tumorigenicity and invasiveness by targeting the matrix metalloproteinase inhibitor RECK. Biochim Biophys Acta 1830 2013:3067–3076.

Lui WO, Pourmand N, Patterson BK, Fire A. Patterns of known and novel small RNAs in human cervical cancer. Cancer Res 2007;67:6031–43.

Wang X, Tang S, Le SY, Lu R, Rader JS, Meyers C, et al. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for

Cancer cell growth. PLoS One 2008;3:e2557.

Tao J, Lu Q, Wu D, et al. microRNA-21 modulates cell proliferation and sensitivity to doxorubicin in bladder cancer cells. Oncol Rep 2011;25:1721e1729

Ning, F.L., et al., MicroRNA-182 modulates chemosensitivity of human non-small cell lung cancer to cisplatin by targeting PDCD4. Diagn Pathol, 2014. 9: p. 143.